Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives.
Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives, from retirement planning to how much they can spend on groceries, according to a report from Consumer Reports.
The report is based on a survey of a nationally representative sample of consumers as well as a survey asking physicians how they address the issue of medication affordability. Survey respondents reported that had to make tradeoffs between paying for the medications they needed and necessities such as groceries and health care. Health insurance plans with very high deductibles forced many to shop around for lower prices and not use their insurance, said Lisa Gill, deputy editor of Consumer Reports Best Buy Drugs.
“Consumers aren’t used to questioning prices for pharmaceutical drugs—nor are they used to shopping around and haggling—but they could save themselves a lot of money if they do,” Gill said in a statement.
The new report found that consumers who experienced higher drug prices in the last 12 months were more likely to economize with their health in potentially dangerous ways. The following statistics compare all survey respondents taking a prescription drug with those who experienced a price increase: not complying with prescription medications to save money (33% vs 47%), putting off doctors’ visits because of cost (18% vs 28%), declining a medical test or procedure because of cost (14% vs 23%), and not filling a prescription because of cost (17% vs 30%), taking an expired medication (12% vs 19%), or not taking a scheduled dosage or prescribed medication to save money (10% vs 17%).
The survey also found that in the past year, consumers who took prescription medications took the following steps in order to pay for their prescription medications: spent less on entertainment and dining out (24% of all respondents vs 38% of those experiencing a price increase), got an insurance policy that covered medications (20% vs 24%), spent less on groceries (17% vs 31%), used credit cards more often (15% vs 25%), spend less on family (14% vs 25%), postponed paying other bills (11% vs 19%), postponed retirement to maintain health insurance coverage (6% vs 10%), and took a second job(4% vs 7%).
Consumer Reports identified 5 key reasons for the rise in drug prices profiled in their report:
Finally, the survey found that despite the burdens created by higher drug prices, only one-fourth of consumers surveyed said they discussed drug costs with their practitioners. Of those who did have such a discussion, 64% said they initiated it--a finding corroborated by the results of Consumer Report’s survey of internal medicine physicians. The physicians said in a typical week they discuss drug costs with only 2.6 of 10 patients, even though 80% of the physicians said they were concerned about their patients’ ability to pay for their treatments.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More